from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0823c/-

LFCtreatmentdescriptionclass of inhibitor

0.005

Amikacinug/mL Amikacintranslation

-0.385

Cap5-10ug/mL Capreomycintranslation

-0.883

Rox10-50 ug/mL Roxithromycintranslation

0.174

SM2-5 ug/mL Streptomycintranslation

-0.164

Tet5-10 ug/mL Tetracyclinetranslation

-0.785

Rif0.2-5ug/mL Rifampicintranscription

0.096

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.955

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.228

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.123

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.732

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.525

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.867

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.359

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.178

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.058

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.199

Nigericin50 uM Nigericinrespiration

-0.854

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.617

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.300

menadione6-10 ug/mL Menadionerespiration

0.720

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.047

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.471

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.026

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.880

NRP_1Non-replicating persistence stage 1dosRassociated

0.014

Amp0.2mg/mL AmpicillincellWall

0.244

Cephalexin20-100 ug/mL CephalexincellWall

-0.925

Cerulenin0.32-5 ug/mL CerulenincellWall

0.453

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.329

EMB10-20 ug/mL EthambutolcellWall

-0.486

Eta12-40 ug/mL EthionamidecellWall

-0.734

INH0.2-0.4 ug/mL IsoniazidcellWall

0.044

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.973

BZA0.12 mg/mL BenzamidearomaticAmides

1.220

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.319

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.167

H2O24 mM hydrogen peroxideDNAdamaging

-0.079

Levo10 ug/mL LevofloxacinDNAdamaging

-0.219

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.147

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.318

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.030

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.565

Antimycin12.5-50 ug/mL Antimycin A?

-0.591

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.368

PA_110-50 ug/mL Antitubercular compound PA-1?

0.225

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.274

PA8240.2-2 ug/mL PA-824?

0.697

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.000

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.288

Verapamil50 uM Verapamil?

-0.545

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.272

methoxatin10-20 ug/mL Methoxatin?